Skip to main content

News

EPIC Skin study launch

OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of Skin Cancer

The multi-centre prospective study will evaluate the efficacy of the Rhenium-SCT® in non-melanoma skin cancer patients

Garching n. Munich, Germany–…

Read more
Map of australia displaying location of rhenium-sct production location

Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Read more
keloid developed from a cesarian scar

New Non-Invasive Keloid Treatment using Rhenium-188 now available in South Africa

Province of Gauteng South Africa is first to offer an innovative single session keloid treatment without need of surgery 

Read more
Map of australia with oncobeta applicator

OncoBeta Announces Approval and ARTG Listing of Rhenium-SCT (Rhenium-188 paste) in Australia for the treatment of skin cancer lesions and skin tumors

Garching n. Munich, Germany, (December 18th, 2020) – OncoBeta® GmbH and their subsidiary OncoBeta Therapeutics Pty Ltd. Australia a Medical Device…

Read more
Map of australia with oncobeta applicator

OncoBeta GmbH and Australian Nuclear Science and Technology Organisation sign Letter of Intent to establish manufacturing site in Australia

Innovative medical device Rhenium-SCT therapy for Non-Melanoma Skin Cancer to be produced in Australia

Read more
map of south america with brazil in blue

Group RPH and OncoBeta GmbH sign agreement for Sales Referral and Distribution of Rhenium-SCT® in Brazil.

Grupo RPH is now the Official Rhenium-SCT® Sales Representative and Distributor in Brazil for the treatment of Non-Melanoma Skin Cancer.

Read more
study graphic

Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study

Abstract Objectives This study aimed to provide long-term clinical data about an innovative epidermal radioisotope therapy called Rhenium-SCT® (Skin…

Read more
oncobeta generator

China Isotope & Radiation Corporation (CIRC) and OncoBeta sign distribution agreement for Tungsten 188/Rhenium-188 generators

Beijing, China and Garching near Munich, Germany, Tuesday 30th June 2020. CIRC and OncoBeta today announced that they have signed an agreement for the…

Read more
skin cancer risk factors infographic

How can you Reduce the Risk of Skin Cancer?

Skin Cancer is the most common type of cancer in the world 1. Ultraviolet (UV) Radiation exposure is one of the major causes of melanoma and…

Read more
covid 19 information

COVID-19: We are here for you.

To our Valued Patients, Customers and Health Care providers, As we navigate through these trying times surrounding the Coronavirus (COVID-19)…

Read more